Assessment of direct oral anticoagulants administered as potentially inappropriate medications to elderly inpatients

被引:0
|
作者
Nanbo Zheng
Xiaonian Han
Lirong Peng
Xiaojing Nie
Jinping Wang
Li Ma
Xin Zan
机构
[1] Xi’an Central Hospital,Department of Pharmacy
来源
International Journal of Clinical Pharmacy | 2020年 / 42卷
关键词
Beers criteria; China; Direct oral anticoagulants; DOACs; Elderly; Guideline; Inpatients; Potentially inappropriate medications;
D O I
暂无
中图分类号
学科分类号
摘要
Background There is evidence that direct oral anticoagulants administered as potentially inappropriate medications increase the risk of bleeding and thromboembolic complications, which represent serious threats to human health. Objective To identify direct oral anticoagulants administered as potentially inappropriate medications for hospitalized patients aged ≥ 65 years in our hospital, and to determine associated factors and the correlation between potentially inappropriate medications and adverse reactions. Setting Xi’an Central Hospital, China. Method A retrospective cross-sectional study of elderly hospitalized patients who received either dabigatran or rivaroxaban at Xi’an Central Hospital between June 1, 2018 and June 1, 2019. The evaluation criteria of direct oral anticoagulants were formulated based on drug labels, disease guidelines and the 2019 American Geriatrics Society Beers Criteria, and any non-compliance with the criteria was considered to be potentially inappropriate medications. The Pearson chi-square test and a binary logistic regression model were used. Main outcome measure Factors associated with potentially inappropriate medications and correlation between potentially inappropriate medications and adverse reactions. Results This study analysed 315 patients aged ≥ 65 years. The application of our evaluation criteria identified 155 (49.2%) instances of potentially inappropriate medications, comprising 5 different types of potentially inappropriate medications. Fifteen adverse drug reactions occurred in the study participants. The Pearson chi-square test revealed significant differences in number of medications (p = 0.021) and creatinine clearance rate (p = 0.002) between potentially inappropriate medications and non-potentially inappropriate medications groups. In the binary logistic regression model, potentially inappropriate medications use was associated with creatinine clearance (creatinine clearance < 30: OR = 3.590, 95% CI = 1.214–10.615, p = 0.021), and there was no significant correlation between potentially inappropriate medications and adverse drug reactions after eliminating the confounding factors (age, length of hospitalization, number of disease combined) with p values of less than 0.25 (adjusted OR = 0.372, 95% CI = 0.117–1.182, p = 0.094). Conclusion This study revealed that the incidence of potentially inappropriate medications was relatively high, number of medications and creatinine clearance differed significantly between potentially inappropriate medications and non-potentially inappropriate medications groups, and potentially inappropriate medications was associated with creatinine clearance (creatinine clearance < 30 mL/min), but there was no significant correlation between potentially inappropriate medications and adverse drug reactions after eliminating the confounding factors.
引用
收藏
页码:871 / 878
页数:7
相关论文
共 50 条
  • [31] Potentially inappropriate medications (PIMs): a survey of their usage in older hospital inpatients
    Kelly, L.
    O'Sullivan, R.
    Berry, A.
    Varghese, P.
    Rudden, A.
    AUSTRALASIAN JOURNAL ON AGEING, 2018, 37 : 31 - 31
  • [32] Re: Prevalence and Determinants of Use of Potentially Inappropriate Medications in Elderly Inpatients: A Prospective Study in a Tertiary Healthcare Setting
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2015, 193 (03): : 955 - 955
  • [33] Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients
    Kampouraki, Emmanouela
    Avery, Peter
    Biss, Tina
    Wynne, Hilary
    Kamali, Farhad
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (05) : 790 - 801
  • [34] Potentially inappropriate medications for elderly with hypertension according to Beers criteria
    Rego, Anderson da Silva
    Cardoso da Silva Rodrigues, Thamires Fernandes
    Bellini, Luana Cristina
    daSilva, Marcelo
    da Cruz Scardoelli, Marcia Glaciela
    deOliveira, Rosana Rosseto
    Nogueira Sanches, Rafaely de Cassia
    Charlo, Patricia Bossolani
    Figueiredo Matozo, Isabelle Cristine
    Druciak, Cristiane de Azevedo
    Salci, Maria Aparecida
    Trindade Radovanovic, Cremilde Aparecida
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (04): : 768 - 768
  • [35] The analysis of the use of potentially inappropriate medications in elderly in the Slovak Republic
    Stanislava Jankyova
    Dominika Rubintova
    Tatiana Foltanova
    International Journal of Clinical Pharmacy, 2020, 42 : 100 - 109
  • [36] Potentially inappropriate medications in the elderly: a French consensus panel list
    Laroche, Marie-Laure
    Charmes, Jean-Pierre
    Merle, Louis
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (08) : 725 - 731
  • [37] Brazilian consensus of potentially inappropriate medications in the elderly: preliminary data
    Oliveira, M.
    Borja-Oliveira, C. R.
    Amorim, W.
    Coqueiro, H. L.
    Gusmao, L. C.
    Carvalho, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S69 - S69
  • [38] Potentially inappropriate medications in the elderly: a French consensus panel list
    Marie-Laure Laroche
    Jean-Pierre Charmes
    Louis Merle
    European Journal of Clinical Pharmacology, 2007, 63 : 725 - 731
  • [39] The analysis of the use of potentially inappropriate medications in elderly in the Slovak Republic
    Jankyova, Stanislava
    Rubintova, Dominika
    Foltanova, Tatiana
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 100 - 109
  • [40] Interventions to deprescribe potentially inappropriate medications in the elderly: Lost in translation?
    Baumgartner, Andrew D.
    Clark, Collin M.
    LaValley, Susan A.
    Monte, Scott V.
    Wahler, Robert G.
    Singh, Ranjit
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (03) : 453 - 461